Effects of a potent platelet-activating factor antagonist, SR27417A, on allergen-induced asthmatic responses

American Journal of Respiratory and Critical Care Medicine

Volumn 156, Issue 1, 1997, Pages 11-16

  Evans, David J ^b   Barnes, Peter J ^a   Cluzel, Marc ^b   O'Connor, Brian J ^b  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; FOROPAFANT; HISTAMINE; PLACEBO; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR RECEPTOR;

AIRWAY; ALLERGIC ASTHMA; ARTICLE; BRONCHOSPASM; CHEMOTAXIS; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HUMAN; INFLAMMATION; LUNG FUNCTION TEST; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE ACTIVATION; TREATMENT OUTCOME;

EID: 0030788620     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.156.1.9611112     Document Type: Article

References (25)

1. Page, C. P., C. B. Archer, W. Paul, and J. Morley. 1984. PAF-acether: a mediator of inflammation and asthma. Trends Pharmacol. Sci. 4:239-241.
2. Barnes, P. J., K. F. Chung, and C. P. Page. 1987. Platelet activating factor as a mediator of allergic disease. J. Allergy Clin. Immunol. 81:919-934.
3. Kroegel, C., T. Yukawa, G. Dent, P. Venge, K. F. Chung, and P. J. Barnes. 1989. Stimulation of degranulation from human eosinophils by platelet-activating factor. J. Immunol. 142:3518-3526.
4. Cuss, F. M., C. M. S. Dixon, and P. J. Barnes. 1986. Effects of inhaled platelet activating factor on pulmonary function and bronchial responsiveness in man. Lancet ii:189-192.
5. Rubin, A. H., L. J. Smith, and R. Patterson. 1987. The bronchoconstrictor properties of platelet activating factor in humans. Am. Rev. Respir. Dis. 136:1145-1151.
6. Spencer, D. A., S. E. Green, J. M. Evans, P. J. Piper, and J. F. Costello. 1990. Platelet activating factor does not cause a reproducible increase in bronchial responsiveness in normal man. Clin. Exp. Allergy 20:525-542.
7. Lai, C. K. W., J. R. Jenkins, R. Polosa, and S. T. Holgate. 1990. Inhaled PAF fails to induce airway hyperresponsiveness to methacholine in normal human subjects. J. Appl. Physiol. 68:919-926.
8. Stenton, S. C., E. N. Court, W. P. Kingston, P. Goadby, C. A. Kelly, M. Duddridge, C. Ward, D. J. Hendrick, and E. H. Walters. 1990. Platelet activating factor in bronchoalveolar lavage fluid from asthmatic subjects. Eur. Respir. J. 3:408-413.
9. Chan-Yeung, M., S. Lam, H. Chan, K. S. Tse, and H. Salari. 1991. The release of platelet activating factor into plasma during allergen-induced bronchoconstriction. J. Allergy Clin. Immunol. 87:667-673.
10. Freitag, A., R. M. Watson, G. Matsos, C. Eastwood, and P. M. O'Byrne. 1993. Effect of a platelet activating factor antagonist, WEB 2086, on allergen induced asthmatic responses. Thorax 48:589-594.
11. Kuitert, L. M., K. P. Hui, S. Uthayarkumar, W. Burke, A. C. Newland, S. Uden, and N. C. Barnes. 1993. Effect of the platelet-activating factor antagonist UK-75,505 on the early and late responses to allergen. Am. Rev. Respir. Dis. 147:82-86.
12. Herbert, J. M., A. Bernat, G. Valette, V. Gigo, A. Lale, M. C. Laplace, L. Lespy, P. Savi, J. P. Maffrand, and G. Le Fur. 1991. Biochemical and pharmacological activities of SR27417, a highly potent, long acting platelet-activating factor receptor antagonist. J. Pharmacol. Exp. Ther. 259:44-51.
13. Herbert, J. M., M. C. Laplace, C. Cailleau, and J. P. Maffrand. 1993. Effect of SR27417 on the binding of [3H]PAF to rabbit and human platelets and human polymorphonuclear leukocytes. J. Lipid Mediat. 7:57-78.
14. De Monchy, J. G. R., H. K. Kauffman, P. Venge, G. H. Koeter, H. N. Jansen, H. J. Sluiter, and K. DeVries. 1985. Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. Am. Rev. Respir. Dis. 131:373-376.
15. Spence, D. P. S., S. L. Johnston, P. M. A. Calverley, P. Dhillon, C. Higgins, E. Ramhamadany, S. Turner, A. Winning, J. Winter, and S. T. Holgate. 1994. The effect of the orally active platelet-activating factor WEB 2086 in the treatment of asthma. Am. J. Respir. Crit. Care Med. 149:1142-1148.
16. Kuitert, L. M., R. M. Angus, N. C. Barnes, P. J. Barnes, M. F. Bone, K. F. Chung, A. J. Fairfax, T. W. Higgenbotham, B. J. O'Connor, B. Piotrowska, J. Rozniecki, S. Uden, E. Hayden, and C. J. Willard. 1995. Effect of a novel potent platelet activating antagonist. Modipafent, in clinical asthma. Am. J. Respir. Crit. Care Med. 151:1331-1335.
17. Adamus, W. S., H. O. Heuer, C. J. Meade, and J. C. Schilling. 1990. Inhibitory effects of a new PAF acethcr antagonist, WEB 2086, on pharmacological changes induced by PAF inhalation in human beings. Clin. Pharmacol. Ther. 47:456-462.
18. O'Connor, B. J., S. Uden, T. J. Carty, J. D. Eskra, P. J. Barnes, and K. F. Chung. 1994. Inhibitory effect of UK75,505, a potent and specific oral platelet-activating factor (PAF) receptor antagonist, on airway and systemic responses to inhaled PAF in humans. Am. Rev. Respir. Dis. 150:35-40.
19. Guinot, P., C. Brambilla, J. Duellier, P. Brquet, and P. Bonvoison. 1987. Effect of BN52063, a specific PAF-acether antagonist on bronchial provocation test to allergen in asthmatic patients: a preliminary study. Prostaglandins 34:723-731.
20. Hsieh, K.-H. 1991. Effects of a PAF antagonist, BN52021, on the PAF-, methacholine-, and allergen-induced bronchoconstriction in asthmatic children. Chest 99:877-882.
21. Bel, E. H., M. De Smet, D. H. Rossing, M. C. Timmers, J. H. Dijkman, and P. J. Sterk. 1991. The effect of a specific oral PAF antagonist, MK287, on antigen-induced early and late reactions in man (abstract). Am. Rev. Respir. Dis. 143:A811.
22. Hwang, S. B. 1990. Specific receptors of platelet activating factor, receptor heterogeneity, and signal transduction mechanisms. J. Lipid Mediat. 2:123-158.
23. Lambrech, G., and M. J. Parnham. 1986. Kadsurenone distinguishes between different platelet activating factor receptor subtypes on macrophages and polymorphonuclear leucocytes. Br. J. Pharmacol. 87: 287-289.
24. Stewart, A. G., and W. A. Phillips. 1989. Intracellular platelet-activating factor regulates eicosanoid generation in guinea-pig resident peritoneal macrophages. Br. J. Pharmacol. 98:141-148.
25. Hozawa, S., Y. Haruta, S. Ishioka, and M. Yamakido. 1995. Effects of a PAF antagonist, Y24180, on bronchial hyperresponsiveness in patients with asthma. Am. J. Respir. Crit. Care Med. 152:1198-1202.